Niger J Paed 2015; 42 (1): 12 –16
ORIGINAL
Audu LI
Improvised bubble continuous
Otuneye AT
positive airway pressure (BCPAP)
Mairami AB
Mukhtar MY
device at the National Hospital
Abuja gives immediate
improvement in respiratory rate
and oxygenation in neonates with
respiratory distress
DOI:http://dx.doi.org/10.4314/njp.v42i1,4
Accepted: 15th August 2014
Abstract: Background: Prematur-
was applied to preterm babies with
ity accounts for 25% of Neonatal
RDS as well as some term babies
Audu LI
(
)
mortality in Nigeria and Respira-
with respiratory distress admitted
Otuneye AT, Mairami AB
tory Distress Syndrome is respon-
into the neonatal intensive care
Mukhtar MY
Department of Paediatrics,
sible for half of these deaths.
units. Respiratory rate, SPO2 and
National Hospital Abuja, Nigeria.
Introducing continuous positive
other signs of respiratory distress
Email: drauduli@yahoo.com
airway pressure for the treatment
were monitored before and at 1
of RDS in Nigeria where health
hour, 6 hours and 12 hours after
care financing is predominantly
the application.
out-of-pocket is quite challenging.
Results: Forty eight newborn
It was hypothesized that applying
babies with respiratory distress
the principle of under-water-seal
were treated with the device out of
pressure generation could convert
whom twenty three (48%) were
a simple oxygen delivery system
very low birth weight with respira-
into an effective Bubble CPAP
tory distress syndrome. The mean
device.
respiratory rate dropped from 64.5
Objectives: To provide evidence
(19.2)/min before commencement
in support of the immediate clini-
of CPAP to 59.5(11.6)/min, 56.6
cal effectiveness of the NH-
(10.5), and 56.6(10.7) at 1, 6 and
BCPAP device.
12 hours respectively, p<0.05. The
Design/Methods: At the neonatal
corresponding values for SPO2
unit of the National Hospital
were 84.5(14) before and 95.9
Abuja, we assembled a circuit of
(5.3), 95.9(6.5) and 96.9(6.4) at 1,
tubing connecting a gas source
6 and 12
hours respectively,
(oxygen concentrator or cylinder)
p<0.05. The respiratory changes
through
an
interface
(nasal
were however less marked among
prongs) to the baby and this was
very low birth weight babies.
further connected through an ex-
Conclusion: The simplified cus-
piratory tube to an under-water-
tomized device produces clinical
seal bottle to generate CPAP. The
responses similar to those reported
device is activated by turning on
for the conventional CPAP
the oxygen source. The device
devices.
Introduction
tions including chronic lung disease of prematurity 3 .
Continuous Positive Airway Pressure (CPAP) is increas-
Prematurity accounts for 25% of neonatal mortality in
ingly used in the management of preterm babies with
Nigeria and respiratory distress syndrome (RDS) is
1
RDS, with a concomitant decrease in the use of
responsible for half of these deaths . Effective manage-
2
mechanical ventilation in tertiary and non- tertiary
health institutions . Respiratory assistance with continu-
4
ment of respiratory distress syndrome is therefore a criti-
cal factor in their survival. Some form of respiratory
ous positive airway pressure (CPAP) is often sufficient
support is required with or without surfactant replace-
to tide a preterm infant through RDS. Introducing CPAP
ment. Mechanical ventilation which was used as the
in a low-resource setting is quite challenging and this
main thrust of respiratory intervention over the years to
has limited its use to a few centers in Nigeria. CPAP
salvage these babies is fraught with several complica-
use may be associated with nasal septum erosion,
13
under-water-seal bottle to generate bubble CPAP . The
5
interference with enteral intake (“CPAP belly”) and
rarely, pneumothorax. Careful selection of appropriate
oxygen flow meter is connected to a humidifier contain-
size nasal prongs, passage of orogastric tube for inter-
ing warm distilled water and this ensures the delivery of
mittent gastric decompression and careful attention to
warm humidified air to the baby. The high flow rate (6-
pressure delivered will minimize these challenges.
8L/Min) prevents re-breathing and carbon dioxide accu-
mulation while also ensuring adequate bubbling and
Adaptation of Bubble –CPAP: Driven by the desire to
under-water pressure generation.
provide effective and yet affordable treatment for RDS
we resorted to the use of locally sourced materials and
Forty eight babies admitted into the newborn unit with
applied the principle of ‘under-water seal’ pressure gen-
respiratory distress (intercostal, subcostal or sternal re-
eration in BCPAP and arrived at a modification of the
cessions, grunting and nasal flaring) over a period of 6
existing bubble CPAP device which is effective, easy to
months were treated with this device. They were clini-
use and remarkably affordable. This has been previously
cally assessed on admission and at 1, 6 and 12hours af-
described .
5
ter commencement of CPAP. Respiratory rates, cyano-
sis, grunting and SPO 2 were documented. Also noted
and documented were baby’s gestational age ( using
Fig 1: NHA B-
mothers’ EDD and Ballard’s score within 24 hours of
CPAP system
birth) , birth weight and diagnosis. The mean (SD) value
of RR and SPO 2 before CPAP was commenced was
compared with the corresponding mean (SD) values at
1,6 and 12 hours after commencement of CPAP and
subjected to statistical analysis (Student t-test) to deter-
mine the significance of observed differences. Babies
who did not improve on CPAP or died while still on
Physiologically, CPAP causes airway splinting, alveolar
CPAP were classified as CPAP failures. The overall
expansion and stabilization, improved alveolar ventila-
mortality rates as well as the case specific mortality rates
tion and enhanced oxygenation . The clinical conse-
6
were also noted.
quences of these are; disappearance of grunting sounds a
drop in the respiratory rate and an improvement in
SPO 2 .
The objective of this communication is to provide evi-
Results
dence in support of the immediate clinical effectiveness
of the NHA-BCPAP device. The findings would provide
Table 1: General characteristics
justification for a planned comparative evaluation of this
(n=45)
device with other conventional commercial CPAP de-
Sex
17(37.8%)
vices. It was hypothesized that application of the NHA
Male
28 (62.2%)
Female
bubble CPAP device to a baby with respiratory distress
Place of delivery (n=48)
would result in an immediate functional improvement in
Inborn
23 (47.9%)
the respiratory status.
Out born
25(52.1%)
Birth weight category (n=48)
ELBW
5(10.4%)
VLBW
18(37.5)
Subjects and methods
LBW
12(25%)
NBW
13(27.1)
This was a prospective observational study in which
Clinical diagnosis
Respiratory Distress Syndrome
30(62.5%)
babies admitted into the newborn unit of the National
Congenital pneumonia
11(22.9%)
Hospital Abuja with respiratory distress were eligible if
Cyanotic Congenital heart disease
3(6.2%)
they had no congenital abnormalities (bilateral choanal
Transient Tachypnoea of the Newborn
2(4.2%)
atresia, congenital diaphragmatic hernia and cleft lip/
Recurrent Apnea
1(2.1%)
palate). These babies would otherwise have received
Hypoxic Ischaemic encephalopathy
1(2.1%)
supplemental intranasal oxygen in addition to other
management relevant to their primary pathologic diag-
Indicators of clinical effectiveness (tables 2-5 )
nosis. There are no facilities for mechanical ventilation
and only a limited number of variable-flow nasal CPAP
The respiratory rate dropped from a mean (SD) value of
devices are available in the unit. Babies were recruited
64.1 (18.3)/min to 59.5 (11.7)/min within 1 hour of
into the study following parental informed consent and
commencing CPAP and this downward trend was main-
Hospital ethics committee approval.
tained, achieving a level of statistical significance at 6
and 12 hours post commencement. The changes ob-
A circuit of tubing attached to a gas source (oxygen cyl-
served in the SPO 2 levels also followed the same pattern
inder or concentrator) was connected through an inter-
albeit more rapidly and this was synchronous with im-
face (nasal prongs) to the baby and this was further con-
provement in the level of cyanosis and the disappear-
nected through an expiratory limb of the tube to an
ance of grunting sound. Further stratification of the
babies into different Birth Weight categories as shown
14
in tables shows that respiratory rate changes are only
were: ELBW (60%), VLBW (33%), LBW (44%) and
significant for the LBW and NBW babies, whereas the
NBW (30%).
changes in SPO2 are uniformly significant across birth
Table 6 shows the case specific mortality rates with
weight categories .
100% mortality for recurrent apnoea and severe hypoxic
Two extremely low birth weight babies and two with
encephalopathy.
suspected cyanotic congenital heart disease had SPO2
persistently below 82% throughout the period of obser-
Table 6: Case specific mortality rate
vation. In six babies (4 VLBW, 2 ELBW), CPAP was
Diagnosis
Mortality Rate
reapplied after weaning, as a result of worsening respira-
Respiratory Distress Syndrome
5(16.7%)
tory distress. The P values were determined by compar-
Congenital pneumonia
1(9.1%)
ing the mean (SD) values at 1 hr, 6 hrs and 12 hrs inde-
Cyanotic Congenital heart disease
2 (66.7%)
pendently with the mean (SD) at 0 hr.
Transient Tachypnoea of the Newborn
0(0%)
Recurrent Apnea
1(100%)
Hypoxic Ischaemic Encephalopathy
1(100%)
Table 2: Indicators of clinical effectiveness
Variable
CPAP
Duration
Discussion
0 hr
1hr
6hrs
12hrs
Mean (SD)RR/min
64.1
59.5
56.6
56.6
Low-cost and simplified forms of the CPAP delivery
systems have been described
7,8
(18.3)
(11.7)
(10.4)
(10.7)
. The uniqueness of our
P value
0.145
0.015
0.016
customized device lies in its simplicity and cost effec-
tiveness. Some other modified BCPAP devices report-
edly use corrugated tubes, Hudson’s nasal prongs or
9
Mean (SD)
84.5
95.9
95.9
96.9
shortened endotracheal tubes which need to be sourced
7
SPO 2
(14.0)
(5.3)
(6.5)
(6.4)
P value
0.0001
0.0001
0.0001
separately, with additional cost burden.
Respiratory Distress Syndrome in very premature neo-
nates is an important indication for nasal CPAP
10,11,12
.
Table 3: Respiratory rates (per minute) before and after com-
However, CPAP has also been successfully used in
mencement of B CPAP in relation to birth weight category
infants with other respiratory conditions, for instance,
NS=not significant
Jocelyn Brown et al
13
in Malawi, demonstrated the ef-
Birth
0 hour
1 hour
6 hour
12 hour
fectiveness of CPAP in the management of congenital
weight
pneumonia and as well as in an infant with Bronchioli-
category
tis. In our study, we recruited neonates with respiratory
ELBW
50.4(9.3)
51.2(19.8)
51.6(7.7)NS
50.8(12.1)NS
NS
distress syndrome (30) as well as those with respiratory
VLBW
61.5(11.4)
64.1(8.6)
58.6(9.2)NS
57.6(8.5)NS
distress from other causes (18) including pneumonia
NS
and congenital heart disease.
LBW
61.0(12.6)
58.5(9.1)
54.2(11.2)
52.2(9.7)
NS
P=.057
P=.083
NBW
75.6(24.4)
58.4(14.7)
57.2(12.3)
61.0(12.4)
We set out to demonstrate that our novel device pro-
P=.009
P=.004
P=.009
duces physiologic responses similar to those previously
observed and documented with different forms of
Table 4: Changes in SPO 2 (%) in relation gestational age
CPAP. Ongoing observations and monitoring of the
category
clinical condition (respiratory rate, heart rate, grunting
Birth
0 hour
1 hour
(P)
6 hour
(P)
12 hour
(P)
Weight
and cyanosis) and oxygen saturation of patients provide
the best assessment of the effectiveness of CPAP .
14
Category
ELBW
82.6(12.6)
97.0(3.0) 0.06
97.2(2.0) 0.04
97.8(1.8) 0.480
Clinical evidence of an effective CPAP includes a de-
VLBW
87.7(15.0)
97.3(2.2) 0.01
98.3(1.6) 0.01
97.8(9.7) 0.01
clining respiratory rate and heart rate, as well as increas-
LBW
80.0(16.3)
94.7(6.5) 0.01
94.6(8.3) 0.01
91.8(13.2) 0.04
ing oxygenation . In our study, the changes we ob-
15
NBW
83.0(15.0)
94.2(7.7) 0.04
92.6(9.3) 0.07
95.5(4.2) 0.030
served; reduction in respiratory rate, increased SPO 2 ,
Table 5: Variable/sign number of babies with sign
and disappearance of cyanosis as well as grunting, there-
Before CPAP 1hr after CPAP 6hrs after CPAP 12hrs after
fore point to the promising clinical effectiveness of the
customized B-CPAP device. Patrick Wilson et al
16
in
Grunting
8 (79.2%)
26(54.2%)
10(20.8%)
6(12.5%)
Ghana had demonstrated a significant drop in respiratory
Cyanosis
48 (100%)
22(45.8%)
15(31.3%)
10(20.8%)
rate among young children aged three months to two
Ten babies died giving an overall mortality rate of
years with Pneumonia treated with CPAP early in the
20.8%. Two of the five mortalities in the RDS group
course of their illness. The outcome in these babies from
were ELBW, two had sepsis and 1 had recurrent apnoea.
their study was significantly better than those in whom
Two term normal birth weight babies with suspected
there was a delay (1 hour) in commencing CPAP. The
Cyanotic congenital heart disease died before specific
usefulness of pulse oximetry as a monitoring tool for
babies on CPAP was noted by Malik et al
17
Echocardiographic diagnosis could be made. Mortality
who re-
rate was 17.4% among inborn babies and 24% among
ported a rapid rise in SPO 2 to >85% and this was sus-
out born babies. Gestational Age related mortality rates
tained among survivors. This pattern of response is simi-
lar to the findings in our study.
15
The improvement in SPO 2 values (oxygenation) was
most oxygen concentrators deliver 80-85% O 2 . These
quite rapid and this preceded the significant reduction in
tend to provide some window of safety against oxygen
respiratory rate. This is similar to the findings of Wag-
toxicity. The mean values of SPO 2 over the period of
staff et al
18
who reported an immediate improvement in
observation was < 97%, therefore the risk of hyperoxae-
oxygenation when they changed from open-mask to a
mia and the resultant effect on the retina especially in
closed CPAP system in a lung model simulating acute
the ELBW/VLBW babies was expectedly minimized.
respiratory failure. The difference in respiratory changes
Although the level of oxygen saturation associated with
in the birth weight categories may be a reflection of
severe retinopathy of prematurity is not clearly defined,
a Meta analysis by Minghua et al
21
gestational age dependent respiratory rate variability.
on the association
between severe ROP in preterms and SPO2 levels
Majority of the babies who did not respond to CPAP
showed that SPO2 values between 70%-96% in the early
were either extreme LBW or had cyanotic congenital
postnatal weeks was associated with reduced risk of
heart disease. These would have required mechanical
severe ROP. Long term ophthalmologic follow up of
ventilation and intensive haemodynamic assessment and
these babies is however required for early detection of
support respectively. Similarly, babies with recurrent
gestational age dependent, oxygen induced retinopathy.
apnoea and severe hypoxic ischaemic encephalopathy
responded poorly to CPAP (as shown in table 4) pre-
sumably because they were unable to centrally maintain
adequate respiratory drive needed to benefit from CPAP
Conclusion
application. Documented causes of CPAP failure
include extreme low birth weight, recurrent apnoea, neo-
The NHA-BCPAP device produces immediate clinical
natal sepsis/pneumonia
9,18,19
intracranial haemorrhage
responses similar to those reported for the conventional
and non administration of antenatal steroid
20
In the ab-
CPAP devices. It is therefore a viable alternative to the
sence of facilities for arterial blood gases, as is the case
more expensive commercial CPAP devices and is there-
in several hospitals in Nigeria, clinical assessment and
fore recommended for use in tertiary and secondary
bedside pulse oximetry are recommended for monitoring
health centers in low-resource setting. Extended obser-
babies on CPAP.
vations will however be needed to establish its long term
benefits.
The limitation to this study is that our device does not
provide blended oxygen, making it difficult to regulate
Conflict of interest: None
the FiO 2 . However, intermittent passage of air through
Funding: None
the mouth and nostrils into the nasopharyngeal space
cannot be completely ruled out, thus allowing for some
air-oxygen blending in the nasopharynx. Furthermore,
References
1.
Federal Ministry of health. Saving
5.
Audu L I, Otuneye AT, Mukhtar
9.
Shrestha M, Basnet S, Shrestha PS.
newborn lives in Nigeria: New-
MY, Mairami AB, Mshelia LJ,
Bubble Continuous Airway Pres-
born health in the context of the
Garu M. Customized bubble con-
sure in the Neonatal Unit of
integrated Maternal, Newborn and
tinuous airway pressure device at
TUTH. J Nepal Pediatr Society.
Child Health Strategy. 2 edition.
nd
the National Hospital Abuja for the
2010;30(1):64-68
10. Bahareh Bahman-Bijari, MD,
1,*
Abuja: Federal Ministry of Health,
treatment of respiratory distress
Arash Malekiyan, MD, Pedram
1
Save the Children, Jhpiego;
syndrome (RDS). Niger J Paediatr
Niknafs, MD, and Mohammad-
1
2011:26
2013; 40(3)275-277
Reza Baneshi, PhD .Bubble
2
2.
Kamath B d, Maclure E M,
6.
Medha Weerasekera. Non invasive
Goldenberg R L, Job A L. Neona-
respiratory support in the neonate:
CPAP vs Ventilatory CPAP in
tal Mortality from respiratory Dis-
Continuous positive airway pres-
Preterm infants with Respiratory
tress Syndrome: Lessons for low
sure (CPAP) Sri Lanka J Child
Distress Iran J Pediatr. 2011; 21
resource countries. Pediatrics
Health, 2011;40:172-176
(2): 151–158.
2011; 127(6): 1139-1146
7.
Kaur C, Sema A, Beri RS, Puliyel
11. Meyer P, Mildenhol L, Wong M.
3.
Davin M J, Walderman A C. Pul-
JM. A simple circuit to deliver
Outcome of infants <1000g cared
monary complications of Me-
bubbling CPAP. Indian Pediatr
for with Nasal CPAP based strat-
chanical ventilation in neonates.
2008;45(4):312-14
egy. J Paediatr Child Health.
Clin Perinatol 2008; 35(1):273-
8.
Kawaza K, Machen H E, Brown J,
2004;40(1-2):38-41
281
Mwanza Z, Iniguez S, Gest A I et
12. Narendran V, Donovan EF, Hoath
4.
Roberts CL, Badgery-Parker T,
al. Efficacy of a Low-Cost Bubble
SB, Akinbi HT, Steichen, Jobe
Algert CS, Bowen JR,Nassar N.
CPAP System in Treatment of
AH. Early Bubble continuous Air-
Trends in Use of Neonatal CPAP:
Respiratory Distress in a Neonatal
way Pressure and outcomes in
a population-based study. BMC
Ward in Malawi. PLoS ONE ,
extremely Low Birth weight Pre-
Pediatr 2011;11:89
2014;9(1): e86327 DOI: 10.1371/
term Infants. J Perinatol 2003;23
doi:10.1186/1471-2431-11-89
journal.pone.0086327
(3):195-9
16
13. J Brown, H Machen, K Kawaza, Z
17. Malik R K, Gupta R K. A two year
20.
Koti J, Murki S, Gaddam P,
Mwanza, S Iniguez, H Lang, A
experience I Continuous Positive
Reddy A, Reddy MD. Bubble
Gest et al. A High-Value, Low-
Airway Pressure Ventilation using
CPAP for respiratory distress syn-
Cost Bubble Continuous Airway
nasal prongs and pulse oxymetry
drome in preterm infants. Indian
Pressure System for Low resource
MJAFI 2003;59:36-39
Pediatr 2010;47(2):139-43
settings: Technical Assessment
18. Wagstaff TAG, Gloven C, Soni N.
21. Minghua L. Chen, Lois E. H.
and Initial Case Reports. PLoS
Continuous Positive Airway Pres-
Smith, Christian E. L. Dammann,
One. 2013;8(1):e53622. Doi
sure in Acute Respiratory Failure:
Olaf Dammann. High or Low Oxy-
10.1371/journal.pone0053622
The importance of the valve. J
gen Saturation and Severe Reti-
14. Askin D F. Non-invasive Ventila-
Intensive Care Soc 2012;13(1):17-
nopathy of Prematurity: A Meta-
tion in the Neonate. J Perinatal
24
analysis. Paediatr 2010;125;e1483;
Neonatal Nursing 2007;21(4):349-
19. Buch PM, Makwana AM Chu-
DOI: 10.1542/peds.2009-2218
358
dasama RK. Usefulness of Downe
15. Bosomworth J. The occasional
Score as Clinical Assessment tool
acute application of CPAP. Can J
and Bubble CPAP as Primary Res-
Rural Med 2009;14(2):68-72
piratory Support in Neonatal Res-
16. Wilson P T, Moris M C, Biagas K
piratory Distress Syndrome. J
V, Otupiri E, Moresky R T. A
Pediatric Sciences 2013;5(1):176
randomized Clinical Trial Evaluat-
ing Nasal Continuous Airway
Pressure for Acute Respiratory
Distress in a Developing Country.
J Pediatr 2013;162(5):988-992